1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Translational Research Award (FY26 LCRP) is sponsored by U.S. Army Medical Research Acquisition Activity (USAMRAA). This award supports innovative lung cancer research from advanced preclinical studies to pilot clinical trials, aiming to translate discoveries into clinical practice. While focused on lung cancer, the translational and clinical trial aspects align with cancer immunotherapy clinical research.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Broad eligibility for organizations and investigators. Confirm the full requirements in the official notice before applying.
Translational Research Award (FY26 LCRP) is funded by U.S. Army Medical Research Acquisition Activity (USAMRAA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Broad Agency Announcement for Extramural Medical Research is sponsored by U.S. Army Medical Research Acquisition Activity (USAMRAA). This Broad Agency Announcement (BAA) solicits extramural research and development ideas for basic and applied research to support scientific study and experimentation directed toward advancing medical knowledge relevant to both military and civilian medical practice.
United States Army Medical Research and Development Command Broad Agency Announcement (USAMRDC BAA) is sponsored by U.S. Army Medical Research Acquisition Activity (USAMRAA). The USAMRDC BAA is a continuously open announcement soliciting extramural research and development ideas to benefit both military and civilian medical practice and knowledge. Pre-proposals/pre-applications are required and can be submitted at any time.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleThe August 31 RFA for Round 2 of NY BRICKS makes $75 million available with a December 7 deadline — but the eligibility threshold jumped from 20 points to 31, the minimum award score went from 70 to 85, property acquisition became an ineligible use, and the renovation set-aside shrank 86 percent.
Read articleIDNR's OSLAD program closes at 5:00 p.m. on August 31, 2026, with $37.5 million available, a $1,125,000 ceiling for land acquisition and $600,000 for development. The standard deal is 50/50. The deal that matters for small towns is the full-funding provision for economically distressed communities — and the thing that disqualifies applicants is not the project, it is GATA prequalification.
Read article